000128984812/312022Q3false312023-07-30three00012898482022-01-012022-09-3000012898482022-10-25xbrli:shares00012898482022-09-30iso4217:USD00012898482021-12-31iso4217:USDxbrli:shares00012898482022-07-012022-09-3000012898482021-07-012021-09-3000012898482021-01-012021-09-300001289848us-gaap:RetainedEarningsMember2022-07-012022-09-300001289848us-gaap:RetainedEarningsMember2022-01-012022-09-300001289848us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-07-012022-09-300001289848us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-09-300001289848us-gaap:CommonStockMember2022-06-300001289848us-gaap:TreasuryStockMember2022-06-300001289848us-gaap:AdditionalPaidInCapitalMember2022-06-300001289848us-gaap:RetainedEarningsMember2022-06-300001289848us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-06-3000012898482022-06-300001289848us-gaap:CommonStockMember2022-07-012022-09-300001289848us-gaap:TreasuryStockMember2022-07-012022-09-300001289848us-gaap:AdditionalPaidInCapitalMember2022-07-012022-09-300001289848us-gaap:CommonStockMember2022-09-300001289848us-gaap:TreasuryStockMember2022-09-300001289848us-gaap:AdditionalPaidInCapitalMember2022-09-300001289848us-gaap:RetainedEarningsMember2022-09-300001289848us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-09-300001289848us-gaap:CommonStockMember2021-06-300001289848us-gaap:TreasuryStockMember2021-06-300001289848us-gaap:AdditionalPaidInCapitalMember2021-06-300001289848us-gaap:RetainedEarningsMember2021-06-300001289848us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-06-3000012898482021-06-300001289848us-gaap:RetainedEarningsMember2021-07-012021-09-300001289848us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-07-012021-09-300001289848us-gaap:CommonStockMember2021-07-012021-09-300001289848us-gaap:TreasuryStockMember2021-07-012021-09-300001289848us-gaap:AdditionalPaidInCapitalMember2021-07-012021-09-300001289848us-gaap:CommonStockMember2021-09-300001289848us-gaap:TreasuryStockMember2021-09-300001289848us-gaap:AdditionalPaidInCapitalMember2021-09-300001289848us-gaap:RetainedEarningsMember2021-09-300001289848us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-09-3000012898482021-09-300001289848us-gaap:CommonStockMember2021-12-310001289848us-gaap:TreasuryStockMember2021-12-310001289848us-gaap:AdditionalPaidInCapitalMember2021-12-310001289848us-gaap:RetainedEarningsMember2021-12-310001289848us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-310001289848us-gaap:CommonStockMember2022-01-012022-09-300001289848us-gaap:TreasuryStockMember2022-01-012022-09-300001289848us-gaap:AdditionalPaidInCapitalMember2022-01-012022-09-300001289848us-gaap:CommonStockMember2020-12-310001289848us-gaap:TreasuryStockMember2020-12-310001289848us-gaap:AdditionalPaidInCapitalMember2020-12-310001289848us-gaap:RetainedEarningsMember2020-12-310001289848us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-12-3100012898482020-12-310001289848us-gaap:RetainedEarningsMember2021-01-012021-09-300001289848us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-01-012021-09-300001289848us-gaap:CommonStockMember2021-01-012021-09-300001289848us-gaap:TreasuryStockMember2021-01-012021-09-300001289848us-gaap:AdditionalPaidInCapitalMember2021-01-012021-09-30hurn:Segmenthurn:operating_industry0001289848hurn:HealthcareSegmentMember2021-12-310001289848hurn:EducationMember2021-12-310001289848hurn:CommercialMember2021-12-310001289848hurn:HealthcareSegmentMember2022-01-012022-09-300001289848hurn:EducationMember2022-01-012022-09-300001289848hurn:CommercialMember2022-01-012022-09-300001289848hurn:HealthcareSegmentMember2022-09-300001289848hurn:EducationMember2022-09-300001289848hurn:CommercialMember2022-09-300001289848hurn:HealthcareSegmentMember2022-01-01xbrli:pure0001289848hurn:EducationMember2022-01-010001289848hurn:CommercialMember2022-01-01hurn:Reporting_Unit0001289848us-gaap:CustomerRelationshipsMembersrt:MinimumMember2022-01-012022-09-300001289848srt:MaximumMemberus-gaap:CustomerRelationshipsMember2022-01-012022-09-300001289848us-gaap:CustomerRelationshipsMember2022-09-300001289848us-gaap:CustomerRelationshipsMember2021-12-310001289848us-gaap:TechnologyBasedIntangibleAssetsMembersrt:MinimumMember2022-01-012022-09-300001289848srt:MaximumMemberus-gaap:TechnologyBasedIntangibleAssetsMember2022-01-012022-09-300001289848us-gaap:TechnologyBasedIntangibleAssetsMember2022-09-300001289848us-gaap:TechnologyBasedIntangibleAssetsMember2021-12-310001289848us-gaap:TradeNamesMember2022-01-012022-09-300001289848us-gaap:TradeNamesMember2022-09-300001289848us-gaap:TradeNamesMember2021-12-310001289848us-gaap:NoncompeteAgreementsMembersrt:MinimumMember2022-01-012022-09-300001289848us-gaap:NoncompeteAgreementsMembersrt:MaximumMember2022-01-012022-09-300001289848us-gaap:NoncompeteAgreementsMember2022-09-300001289848us-gaap:NoncompeteAgreementsMember2021-12-310001289848us-gaap:CustomerContractsMember2022-01-012022-09-300001289848us-gaap:CustomerContractsMember2022-09-300001289848us-gaap:CustomerContractsMember2021-12-310001289848hurn:ReleaseofAllowanceMember2021-07-012021-09-300001289848hurn:ChangeinEstimatedVariableConsiderationMember2021-07-012021-09-300001289848hurn:ChangeinEstimatedVariableConsiderationMember2022-01-012022-09-300001289848hurn:ReleaseofAllowanceMember2022-01-012022-09-300001289848hurn:ChangeinEstimatedVariableConsiderationMember2021-01-012021-09-300001289848hurn:ReleaseofAllowanceMember2021-01-012021-09-3000012898482022-10-012022-09-3000012898482023-01-012022-09-3000012898482024-01-012022-09-300001289848hurn:ShareRepurchaseProgramMember2020-11-300001289848hurn:ShareRepurchaseProgramMember2022-09-300001289848hurn:ShareRepurchaseProgramMemberus-gaap:SubsequentEventMember2022-10-310001289848hurn:ShareRepurchaseProgramMember2022-07-012022-09-300001289848hurn:ShareRepurchaseProgramMember2022-01-012022-09-300001289848hurn:ShareRepurchaseProgramMember2022-01-012022-03-310001289848hurn:ShareRepurchaseProgramMember2021-12-310001289848hurn:ShareRepurchaseProgramMember2021-07-012021-09-300001289848hurn:ShareRepurchaseProgramMember2021-01-012021-09-300001289848hurn:SeniorSecuredCreditFacilityMember2022-09-300001289848hurn:SeniorSecuredCreditFacilityMember2021-12-310001289848hurn:PromissoryNotedue2024Member2022-09-300001289848hurn:PromissoryNotedue2024Member2021-12-310001289848hurn:SeniorSecuredCreditFacilityMember2015-03-310001289848hurn:SeniorSecuredCreditFacilityMember2015-03-312015-03-310001289848hurn:SeniorSecuredCreditFacilityMemberus-gaap:LondonInterbankOfferedRateLIBORMembersrt:MinimumMember2015-03-312015-03-310001289848srt:MaximumMemberhurn:SeniorSecuredCreditFacilityMemberus-gaap:LondonInterbankOfferedRateLIBORMember2015-03-312015-03-310001289848hurn:SeniorSecuredCreditFacilityMemberus-gaap:BaseRateMembersrt:MinimumMember2015-03-312015-03-310001289848srt:MaximumMemberhurn:SeniorSecuredCreditFacilityMemberus-gaap:BaseRateMember2015-03-312015-03-310001289848hurn:PromissoryNotedue2024Member2017-06-300001289848hurn:PromissoryNotedue2024Member2017-06-302017-06-300001289848hurn:PromissoryNotedue2024Memberhurn:AircraftSecurityAgreementMember2021-12-310001289848hurn:AircraftSecurityAgreementMember2021-12-310001289848hurn:PromissoryNotedue2024Member2022-01-012022-03-310001289848hurn:PreviouslyVacatedOfficeSpaceMember2022-07-012022-09-300001289848us-gaap:ContractTerminationMember2022-07-012022-09-300001289848us-gaap:EmployeeSeveranceMember2022-07-012022-09-300001289848us-gaap:EmployeeSeveranceMember2022-01-012022-09-300001289848hurn:PreviouslyVacatedOfficeSpaceMember2022-01-012022-09-300001289848hurn:TransactionExpensesMember2022-01-012022-09-300001289848us-gaap:ContractTerminationMember2022-01-012022-09-300001289848hurn:AcceleratedAmortizationMember2022-01-012022-09-300001289848hurn:BusinessAdvisoryMemberhurn:LifeSciencesMemberhurn:Hurn_LifeSciencesDivestitureGainLossMember2022-01-012022-09-300001289848hurn:TransactionExpensesMember2021-07-012021-09-300001289848hurn:PreviouslyVacatedOfficeSpaceMember2021-07-012021-09-300001289848us-gaap:EmployeeSeveranceMember2021-07-012021-09-300001289848hurn:PreviouslyVacatedOfficeSpaceMember2021-01-012021-09-300001289848hurn:TransactionExpensesMember2021-01-012021-09-300001289848us-gaap:EmployeeSeveranceMember2021-01-012021-09-300001289848us-gaap:EmployeeSeveranceMember2021-12-310001289848hurn:OfficeSpaceReductionsMember2021-12-310001289848us-gaap:OtherRestructuringMember2021-12-310001289848hurn:OfficeSpaceReductionsMember2022-01-012022-09-300001289848us-gaap:OtherRestructuringMember2022-01-012022-09-300001289848us-gaap:EmployeeSeveranceMember2022-09-300001289848hurn:OfficeSpaceReductionsMember2022-09-300001289848us-gaap:OtherRestructuringMember2022-09-300001289848hurn:PreviouslyVacatedOfficeSpaceMember2022-09-300001289848us-gaap:InterestRateSwapMember2022-09-300001289848us-gaap:InterestRateSwapMember2021-12-310001289848us-gaap:InterestRateSwapMember2022-01-012022-09-300001289848us-gaap:ForeignExchangeContractMember2022-09-30iso4217:INR0001289848us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2022-09-300001289848us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember2021-12-310001289848us-gaap:OtherNoncurrentAssetsMember2022-09-300001289848us-gaap:OtherNoncurrentAssetsMember2021-12-310001289848us-gaap:AccruedLiabilitiesMember2022-09-300001289848us-gaap:AccruedLiabilitiesMember2021-12-310001289848us-gaap:OtherNoncurrentLiabilitiesMember2022-09-300001289848us-gaap:OtherNoncurrentLiabilitiesMember2021-12-310001289848us-gaap:ForeignExchangeContractMember2022-01-012022-09-300001289848us-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2022-09-300001289848us-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2022-09-300001289848us-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-09-300001289848us-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMember2022-09-300001289848us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ConvertibleDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Member2022-09-300001289848us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ConvertibleDebtSecuritiesMemberus-gaap:FairValueInputsLevel2Member2022-09-300001289848us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ConvertibleDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Member2022-09-300001289848us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ConvertibleDebtSecuritiesMember2022-09-300001289848us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberhurn:DeferredCompensationPlanAssetsMember2022-09-300001289848us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberhurn:DeferredCompensationPlanAssetsMember2022-09-300001289848us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberhurn:DeferredCompensationPlanAssetsMember2022-09-300001289848us-gaap:FairValueMeasurementsRecurringMemberhurn:DeferredCompensationPlanAssetsMember2022-09-300001289848us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2022-09-300001289848us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2022-09-300001289848us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-09-300001289848us-gaap:FairValueMeasurementsRecurringMember2022-09-300001289848us-gaap:ForeignExchangeContractMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2022-09-300001289848us-gaap:ForeignExchangeContractMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2022-09-300001289848us-gaap:ForeignExchangeContractMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2022-09-300001289848us-gaap:ForeignExchangeContractMemberus-gaap:FairValueMeasurementsRecurringMember2022-09-300001289848us-gaap:FairValueMeasurementsRecurringMemberhurn:ContingentConsiderationLiabilityMemberus-gaap:FairValueInputsLevel1Member2022-09-300001289848us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberhurn:ContingentConsiderationLiabilityMember2022-09-300001289848us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberhurn:ContingentConsiderationLiabilityMember2022-09-300001289848us-gaap:FairValueMeasurementsRecurringMemberhurn:ContingentConsiderationLiabilityMember2022-09-300001289848us-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2021-12-310001289848us-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2021-12-310001289848us-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2021-12-310001289848us-gaap:InterestRateSwapMemberus-gaap:FairValueMeasurementsRecurringMember2021-12-310001289848us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ConvertibleDebtSecuritiesMemberus-gaap:FairValueInputsLevel1Member2021-12-310001289848us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ConvertibleDebtSecuritiesMemberus-gaap:FairValueInputsLevel2Member2021-12-310001289848us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ConvertibleDebtSecuritiesMemberus-gaap:FairValueInputsLevel3Member2021-12-310001289848us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ConvertibleDebtSecuritiesMember2021-12-310001289848us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Memberhurn:DeferredCompensationPlanAssetsMember2021-12-310001289848us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberhurn:DeferredCompensationPlanAssetsMember2021-12-310001289848us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberhurn:DeferredCompensationPlanAssetsMember2021-12-310001289848us-gaap:FairValueMeasurementsRecurringMemberhurn:DeferredCompensationPlanAssetsMember2021-12-310001289848us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel1Member2021-12-310001289848us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Member2021-12-310001289848us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Member2021-12-310001289848us-gaap:FairValueMeasurementsRecurringMember2021-12-310001289848us-gaap:FairValueMeasurementsRecurringMemberhurn:ContingentConsiderationLiabilityMemberus-gaap:FairValueInputsLevel1Member2021-12-310001289848us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel2Memberhurn:ContingentConsiderationLiabilityMember2021-12-310001289848us-gaap:FairValueMeasurementsRecurringMemberus-gaap:FairValueInputsLevel3Memberhurn:ContingentConsiderationLiabilityMember2021-12-310001289848us-gaap:FairValueMeasurementsRecurringMemberhurn:ContingentConsiderationLiabilityMember2021-12-310001289848us-gaap:ConvertibleDebtSecuritiesMemberhurn:ShorelightHoldingsLlcMember2022-09-300001289848srt:ScenarioForecastMemberhurn:ShorelightHoldingsLlcMember2024-01-172024-01-170001289848us-gaap:MeasurementInputDiscountRateMemberus-gaap:ConvertibleDebtSecuritiesMemberhurn:ShorelightHoldingsLlcMember2022-09-300001289848us-gaap:MeasurementInputDiscountRateMemberus-gaap:ConvertibleDebtSecuritiesMemberhurn:ShorelightHoldingsLlcMember2021-12-310001289848us-gaap:ConvertibleDebtSecuritiesMemberus-gaap:MeasurementInputPriceVolatilityMemberhurn:ShorelightHoldingsLlcMember2022-09-300001289848us-gaap:ConvertibleDebtSecuritiesMemberus-gaap:MeasurementInputPriceVolatilityMemberhurn:ShorelightHoldingsLlcMember2021-12-310001289848us-gaap:FairValueMeasurementsRecurringMemberus-gaap:ConvertibleDebtSecuritiesMember2022-01-012022-09-300001289848hurn:ContingentConsiderationLiabilityMember2022-09-300001289848hurn:ContingentConsiderationLiabilityMembersrt:MinimumMember2021-12-310001289848srt:MaximumMemberhurn:ContingentConsiderationLiabilityMember2021-12-310001289848srt:WeightedAverageMemberhurn:ContingentConsiderationLiabilityMember2021-12-310001289848us-gaap:FairValueMeasurementsRecurringMemberhurn:ContingentConsiderationLiabilityMember2022-01-012022-09-3000012898482019-12-310001289848hurn:MedicallyHomeGroupIncMemberus-gaap:PreferredStockMember2021-12-310001289848hurn:MedicallyHomeGroupIncMemberus-gaap:PreferredStockMember2022-01-012022-03-310001289848hurn:MedicallyHomeGroupIncMemberus-gaap:PreferredStockMember2022-03-310001289848hurn:MedicallyHomeGroupIncMemberus-gaap:PreferredStockMember2022-09-300001289848us-gaap:InterestRateSwapMember2022-07-012022-09-300001289848us-gaap:InterestRateSwapMember2021-07-012021-09-300001289848us-gaap:ForeignExchangeContractMember2022-07-012022-09-300001289848us-gaap:ForeignExchangeContractMember2021-07-012021-09-300001289848us-gaap:InterestRateSwapMember2021-01-012021-09-300001289848us-gaap:ForeignExchangeContractMember2021-01-012021-09-300001289848us-gaap:AccumulatedTranslationAdjustmentMember2021-12-310001289848us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2021-12-310001289848us-gaap:ForeignExchangeContractMember2021-12-310001289848us-gaap:AccumulatedTranslationAdjustmentMember2022-01-012022-09-300001289848us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-01-012022-09-300001289848us-gaap:AccumulatedTranslationAdjustmentMember2022-09-300001289848us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember2022-09-300001289848us-gaap:OperatingSegmentsMemberhurn:HealthcareSegmentMember2022-07-012022-09-300001289848us-gaap:OperatingSegmentsMemberhurn:HealthcareSegmentMember2021-07-012021-09-300001289848us-gaap:OperatingSegmentsMemberhurn:HealthcareSegmentMember2022-01-012022-09-300001289848us-gaap:OperatingSegmentsMemberhurn:HealthcareSegmentMember2021-01-012021-09-300001289848hurn:EducationMemberus-gaap:OperatingSegmentsMember2022-07-012022-09-300001289848hurn:EducationMemberus-gaap:OperatingSegmentsMember2021-07-012021-09-300001289848hurn:EducationMemberus-gaap:OperatingSegmentsMember2022-01-012022-09-300001289848hurn:EducationMemberus-gaap:OperatingSegmentsMember2021-01-012021-09-300001289848hurn:CommercialMemberus-gaap:OperatingSegmentsMember2022-07-012022-09-300001289848hurn:CommercialMemberus-gaap:OperatingSegmentsMember2021-07-012021-09-300001289848hurn:CommercialMemberus-gaap:OperatingSegmentsMember2022-01-012022-09-300001289848hurn:CommercialMemberus-gaap:OperatingSegmentsMember2021-01-012021-09-300001289848us-gaap:OperatingSegmentsMember2022-07-012022-09-300001289848us-gaap:OperatingSegmentsMember2021-07-012021-09-300001289848us-gaap:OperatingSegmentsMember2022-01-012022-09-300001289848us-gaap:OperatingSegmentsMember2021-01-012021-09-300001289848us-gaap:MaterialReconcilingItemsMember2022-07-012022-09-300001289848us-gaap:MaterialReconcilingItemsMember2021-07-012021-09-300001289848us-gaap:MaterialReconcilingItemsMember2022-01-012022-09-300001289848us-gaap:MaterialReconcilingItemsMember2021-01-012021-09-300001289848hurn:ConsultingAndManagedServicesCapabilityMemberhurn:HealthcareSegmentMember2022-07-012022-09-300001289848hurn:ConsultingAndManagedServicesCapabilityMemberhurn:HealthcareSegmentMember2021-07-012021-09-300001289848hurn:ConsultingAndManagedServicesCapabilityMemberhurn:HealthcareSegmentMember2022-01-012022-09-300001289848hurn:ConsultingAndManagedServicesCapabilityMemberhurn:HealthcareSegmentMember2021-01-012021-09-300001289848hurn:HealthcareSegmentMemberhurn:DigitalCapabilityMember2022-07-012022-09-300001289848hurn:HealthcareSegmentMemberhurn:DigitalCapabilityMember2021-07-012021-09-300001289848hurn:HealthcareSegmentMemberhurn:DigitalCapabilityMember2022-01-012022-09-300001289848hurn:HealthcareSegmentMemberhurn:DigitalCapabilityMember2021-01-012021-09-300001289848hurn:HealthcareSegmentMember2022-07-012022-09-300001289848hurn:HealthcareSegmentMember2021-07-012021-09-300001289848hurn:HealthcareSegmentMember2021-01-012021-09-300001289848hurn:EducationMemberhurn:ConsultingAndManagedServicesCapabilityMember2022-07-012022-09-300001289848hurn:EducationMemberhurn:ConsultingAndManagedServicesCapabilityMember2021-07-012021-09-300001289848hurn:EducationMemberhurn:ConsultingAndManagedServicesCapabilityMember2022-01-012022-09-300001289848hurn:EducationMemberhurn:ConsultingAndManagedServicesCapabilityMember2021-01-012021-09-300001289848hurn:EducationMemberhurn:DigitalCapabilityMember2022-07-012022-09-300001289848hurn:EducationMemberhurn:DigitalCapabilityMember2021-07-012021-09-300001289848hurn:EducationMemberhurn:DigitalCapabilityMember2022-01-012022-09-300001289848hurn:EducationMemberhurn:DigitalCapabilityMember2021-01-012021-09-300001289848hurn:EducationMember2022-07-012022-09-300001289848hurn:EducationMember2021-07-012021-09-300001289848hurn:EducationMember2021-01-012021-09-300001289848hurn:ConsultingAndManagedServicesCapabilityMemberhurn:CommercialMember2022-07-012022-09-300001289848hurn:ConsultingAndManagedServicesCapabilityMemberhurn:CommercialMember2021-07-012021-09-300001289848hurn:ConsultingAndManagedServicesCapabilityMemberhurn:CommercialMember2022-01-012022-09-300001289848hurn:ConsultingAndManagedServicesCapabilityMemberhurn:CommercialMember2021-01-012021-09-300001289848hurn:CommercialMemberhurn:DigitalCapabilityMember2022-07-012022-09-300001289848hurn:CommercialMemberhurn:DigitalCapabilityMember2021-07-012021-09-300001289848hurn:CommercialMemberhurn:DigitalCapabilityMember2022-01-012022-09-300001289848hurn:CommercialMemberhurn:DigitalCapabilityMember2021-01-012021-09-300001289848hurn:CommercialMember2022-07-012022-09-300001289848hurn:CommercialMember2021-07-012021-09-300001289848hurn:CommercialMember2021-01-012021-09-300001289848hurn:ConsultingAndManagedServicesCapabilityMember2022-07-012022-09-300001289848hurn:ConsultingAndManagedServicesCapabilityMember2021-07-012021-09-300001289848hurn:ConsultingAndManagedServicesCapabilityMember2022-01-012022-09-300001289848hurn:ConsultingAndManagedServicesCapabilityMember2021-01-012021-09-300001289848hurn:DigitalCapabilityMember2022-07-012022-09-300001289848hurn:DigitalCapabilityMember2021-07-012021-09-300001289848hurn:DigitalCapabilityMember2022-01-012022-09-300001289848hurn:DigitalCapabilityMember2021-01-012021-09-30

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549 

FORM 10-Q 

 

(Mark One)

☒			QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2022

OR 

☐			TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number: 000-50976 

HURON CONSULTING GROUP INC.

(Exact name of registrant as specified in its charter)

 

Delaware						01-0666114
(State or other jurisdiction of incorporation or organization)						(IRS Employer Identification Number)

550 West Van Buren Street

Chicago, Illinois

60607

(Address of principal executive offices)

(Zip Code)

(312) 583-8700

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class			Trading Symbol(s)			Name of each exchange on which registered
Common Stock, par value $0.01 per share			HURN			NASDAQ Global Select Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒    No  ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ☒    No  ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company”, and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer

☒

Accelerated Filer

☐

Non-accelerated Filer

☐

Smaller Reporting  Company

☐

Emerging Growth Company

☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ☐    No  ☒

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

As of October 25, 2022, 19,933,479 shares of the registrant’s common stock, par value $0.01 per share, were outstanding.

---

Table of Contents

Huron Consulting Group Inc.

HURON CONSULTING GROUP INC.

INDEX

						Page
Part I – Financial Information
Item 1.			Consolidated Financial Statements (Unaudited)
			Consolidated Balance Sheets			1
			Consolidated Statements of Operations and Other Comprehensive Income			2
			Consolidated Statements of Stockholders’ Equity			3
			Consolidated Statements of Cash Flows			4
			Notes to Consolidated Financial Statements			5
Item 2.			Management’s Discussion and Analysis of Financial Condition and Results of Operations			22
Item 3.			Quantitative and Qualitative Disclosures About Market Risk			41
Item 4.			Controls and Procedures			42
Part II – Other Information
Item 1.			Legal Proceedings			42
Item 1A.			Risk Factors			42
Item 2.			Unregistered Sales of Equity Securities and Use of Proceeds			43
Item 3.			Defaults Upon Senior Securities			43
Item 4.			Mine Safety Disclosures			43
Item 5.			Other Information			43
Item 6.			Exhibits			44
Signature						45

---

Table of Contents

PART I - FINANCIAL INFORMATION

ITEM 1. CONSOLIDATED FINANCIAL STATEMENTS

HURON CONSULTING GROUP INC.

CONSOLIDATED BALANCE SHEETS

(In thousands, except share and per share amounts)

(Unaudited) 

			September 30, 2022						December 31, 2021
Assets
Current assets:
Cash and cash equivalents			$	8,831					$	20,781
Receivables from clients, net of allowances of $10,494 and $8,827, respectively			166,734						122,316
Unbilled services, net of allowances of $3,992 and $2,637, respectively			122,317						91,285
Income tax receivable			213						8,071
Prepaid expenses and other current assets			25,524						15,229
Total current assets			323,619						257,682
Property and equipment, net			26,187						31,004
Deferred income taxes, net			1,625						1,804
Long-term investments			95,854						72,584
Operating lease right-of-use assets			32,112						35,311
Other non-current assets			65,993						68,191
Intangible assets, net			25,453						31,894
Goodwill			623,841						620,879
Total assets			$	1,194,684					$	1,119,349
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable			$	15,115					$	13,621
Accrued expenses and other current liabilities			32,016						22,519
Accrued payroll and related benefits			118,195						139,131
Current maturities of long-term debt			—						559
Current maturities of operating lease liabilities			10,414						10,142
Deferred revenues			20,378						19,212
Total current liabilities			196,118						205,184
Non-current liabilities:
Deferred compensation and other liabilities			31,487						43,458
Long-term debt, net of current portion			341,000						232,221
Operating lease liabilities, net of current portion			48,221						54,313
Deferred income taxes, net			21,597						12,273
Total non-current liabilities			442,305						342,265
Commitments and contingencies
Stockholders’ equity
Common stock; $0.01 par value; 500,000,000 shares authorized; 22,853,524 and 24,364,814 shares issued, respectively			225						239
Treasury stock, at cost, 2,696,264 and 2,495,172 shares, respectively			(137,000)						(135,969)
Additional paid-in capital			336,125						413,794
Retained earnings			335,464						276,996
Accumulated other comprehensive income			21,447						16,840
Total stockholders’ equity			556,261						571,900
Total liabilities and stockholders’ equity			$	1,194,684					$	1,119,349

The accompanying notes are an integral part of the consolidated financial statements.

1

---

Table of Contents

HURON CONSULTING GROUP INC.

CONSOLIDATED STATEMENTS OF OPERATIONS AND OTHER COMPREHENSIVE INCOME (LOSS)

(In thousands, except per share amounts)

(Unaudited) 

			Three Months Ended September 30,												Nine Months Ended September 30,
			2022						2021						2022						2021
Revenues and reimbursable expenses:
Revenues			$	285,370					$	224,007					$	818,744					$	657,346
Reimbursable expenses			6,816						3,690						19,034						8,876
Total revenues and reimbursable expenses			292,186						227,697						837,778						666,222
Operating expenses:
Direct costs (exclusive of depreciation and amortization included below)			193,368						153,902						569,848						463,543
Reimbursable expenses			6,917						3,914						19,249						9,233
Selling, general and administrative expenses			54,458						43,576						148,886						128,574
Restructuring charges			1,332						1,677						4,956						3,166
Depreciation and amortization			6,812						6,322						20,578						19,031
Total operating expenses			262,887						209,391						763,517						623,547
Operating income			29,299						18,306						74,261						42,675
Other income (expense), net:
Interest expense, net of interest income			(3,111)						(2,217)						(7,753)						(5,965)
Other income (expense), net			(785)						(394)						18,699						2,177
Total other income (expense), net			(3,896)						(2,611)						10,946						(3,788)
Income before taxes			25,403						15,695						85,207						38,887
Income tax expense			7,662						1,968						26,739						6,958
Net income			$	17,741					$	13,727					$	58,468					$	31,929
Earnings per share:
Net income per basic share			$	0.88					$	0.65					$	2.85					$	1.48
Net income per diluted share			$	0.86					$	0.64					$	2.80					$	1.46
Weighted average shares used in calculating earnings per share:
Basic			20,109						21,242						20,511						21,574
Diluted			20,615						21,531						20,899						21,904
Comprehensive income (loss):
Net income			$	17,741					$	13,727					$	58,468					$	31,929
Foreign currency translation adjustments, net of tax			(1,034)						(246)						(1,733)						236
Unrealized gain (loss) on investment, net of tax			(830)						1,158						(2,718)						(2,068)
Unrealized gain on cash flow hedging instruments, net of tax			3,762						309						9,058						1,956
Other comprehensive income			1,898						1,221						4,607						124
Comprehensive income			$	19,639					$	14,948					$	63,075					$	32,053

The accompanying notes are an integral part of the consolidated financial statements.

2

---

Table of Contents

HURON CONSULTING GROUP INC.

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(In thousands, except share amounts)

(Unaudited)

			Three Months Ended September 30,
			Common Stock												Treasury Stock												Additional Paid-In Capital						Retained Earnings						Accumulated Other Comprehensive Income						Stockholders’ Equity
			Shares						Amount						Shares						Amount
Balance at June 30, 2022			23,183,446						$	232					(2,935,799)						$	(136,425)					$	374,280					$	317,723					$	19,549					$	575,359
Comprehensive income																																	17,741						1,898						19,639
Issuance of common stock in connection with:
Restricted stock awards, net of cancellations			36,251						—						(835)						(46)						46																		—
Exercise of stock options			6,000						—																		236																		236
Share-based compensation																											7,160																		7,160
Shares redeemed for employee tax withholdings															(8,020)						(529)																								(529)
Share repurchases			(685,641)						(7)																		(45,597)																		(45,604)
Balance at September 30, 2022			22,540,056						$	225					(2,944,654)						$	(137,000)					$	336,125					$	335,464					$	21,447					$	556,261
Balance at June 30, 2021			24,321,728						$	243					(2,899,933)						$	(135,364)					$	429,084					$	232,211					$	11,964					538,138
Comprehensive income																																	13,727						1,221						14,948
Issuance of common stock in connection with:
Restricted stock awards, net of cancellations			45,190						—						1,371						77						(77)																		—
Exercise of stock options			5,000						—																		191																		191
Share-based compensation																											5,693																		5,693
Shares redeemed for employee tax withholdings															(12,489)						(616)																								(616)
Share repurchases			(518,045)						(5)																		(24,981)																		(24,986)
Balance at September 30, 2021			23,853,873						$	238					(2,911,051)						$	(135,903)					$	409,910					$	245,938					$	13,185					$	533,368

			Nine Months Ended September 30,
			Common Stock												Treasury Stock												Additional Paid-In Capital						Retained Earnings						Accumulated Other Comprehensive Income						Stockholders’ Equity
			Shares						Amount						Shares						Amount
Balance at December 31, 2021			23,868,918						$	239					(2,908,849)						$	(135,969)					$	413,794					$	276,996					$	16,840					$	571,900
Comprehensive income																																	58,468						4,607						63,075
Issuance of common stock in connection with:
Restricted stock awards, net of cancellations			341,189						3						114,290						6,509						(6,512)																		—
Exercise of stock options			36,536						—																		1,421																		1,421
Share-based compensation																											25,260																		25,260
Shares redeemed for employee tax withholdings															(150,095)						(7,540)																								(7,540)
Share repurchases			(1,706,587)						(17)																		(97,838)																		(97,855)
Balance at September 30, 2022			22,540,056						$	225					(2,944,654)						$	(137,000)					$	336,125					$	335,464					$	21,447					$	556,261
Balance at December 31, 2020			24,560,855						$	246					(2,812,896)						$	(129,886)					$	454,512					$	214,009					$	13,061					$	551,942
Comprehensive income																																	31,929						124						32,053
Issuance of common stock in connection with:
Restricted stock awards, net of cancellations			443,741						4						82,380						3,250						(3,254)																		—
Exercise of stock options			18,403						—																		613																		613
Share-based compensation																											18,256																		18,256
Shares redeemed for employee tax withholdings															(180,535)						(9,267)																								(9,267)
Share repurchases			(1,169,126)						(12)																		(60,217)																		(60,229)
Balance at September 30, 2021			23,853,873						$	238					(2,911,051)						$	(135,903)					$	409,910					$	245,938					$	13,185					$	533,368

The accompanying notes are an integral part of the consolidated financial statements.

3

---

Table of Contents

HURON CONSULTING GROUP INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

			Nine Months Ended September 30,
			2022						2021
Cash flows from operating activities:
Net income			$	58,468					$	31,929
Adjustments to reconcile net income to cash flows from operating activities:
Depreciation and amortization			20,578						19,245
Non-cash lease expense			4,768						4,912
Share-based compensation			23,083						17,979
Amortization of debt discount and issuance costs			595						595
Allowances for doubtful accounts			47						7
Deferred income taxes			7,133						2,434
Gain on sale of property and equipment, excluding transaction costs			(1,117)						(254)
Change in fair value of contingent consideration liabilities			(34)						98
Change in fair value of preferred stock investment			(26,964)						—
Other, net			6						(78)
Changes in operating assets and liabilities, net of acquisitions and divestiture:
(Increase) decrease in receivables from clients, net			(44,759)						(23,294)
(Increase) decrease in unbilled services, net			(31,937)						(40,883)
(Increase) decrease in current income tax receivable / payable, net			14,704						3,159
(Increase) decrease in other assets			3,468						98
Increase (decrease) in accounts payable and other liabilities			(14,538)						2,229
Increase (decrease) in accrued payroll and related benefits			(18,883)						(35,958)
Increase (decrease) in deferred revenues			(397)						(10,424)
Net cash used in operating activities			(5,779)						(28,206)
Cash flows from investing activities:
Purchases of property and equipment			(9,768)						(8,918)
Investment in life insurance policies			(283)						(574)
Distributions from life insurance policies			2,958						—
Purchases of business, net of cash acquired			(1,948)						(5,886)
Capitalization of internally developed software costs			(6,855)						(3,603)
Proceeds from note receivable			157						—
Proceeds from sale of property and equipment			4,753						255
Divestiture of business			207						—
Net cash used in investing activities			(10,779)						(18,726)
Cash flows from financing activities:
Proceeds from exercises of stock options			1,421						613
Shares redeemed for employee tax withholdings			(7,540)						(9,267)
Share repurchases			(95,474)						(60,229)
Proceeds from bank borrowings			287,000						189,000
Repayments of bank borrowings			(178,780)						(129,362)
Deferred payments on business acquisitions			(1,875)						—
Net cash provided by (used in) financing activities			4,752						(9,245)
Effect of exchange rate changes on cash			(144)						189
Net decrease in cash and cash equivalents			(11,950)						(55,988)
Cash and cash equivalents at beginning of the period			20,781						67,177
Cash and cash equivalents at end of the period			$	8,831					$	11,189
Supplemental disclosure of cash flow information:
Non-cash investing and financing activities:
Property and equipment expenditures and capitalized software included in accounts payable, accrued expenses and accrued payroll and related benefits			$	3,474					$	2,140
Operating lease right-of-use asset obtained in exchange for operating lease liability			$	1,908					$	2,960
Contingent consideration related to purchase of business			$	869					$	—
Share repurchases included in accounts payable			$	2,572					$	—

    The accompanying notes are an integral part of the consolidated financial statements.

4

---

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

1. Description of Business

Huron is a global professional services firm that creates innovative strategies, optimizes operations and accelerates digital transformation using an enterprise portfolio of technology, data and analytics solutions to empower clients to own their future. By collaborating with clients, embracing diverse perspectives, encouraging new ideas and challenging the status quo, we create sustainable results for the organizations we serve.

We provide our services and manage our business under three operating segments: Healthcare, Education and Commercial. See Note 14 “Segment Information” for a discussion of our three segments.

Effective January 1, 2022, we modified our operating model to expand and more deeply integrate our industry expertise with our digital, strategic and financial advisory capabilities. The new operating model will strengthen Huron’s go-to-market strategy, drive efficiencies that support margin expansion, and position the company to accelerate growth.

To align with the new operating model, effective with reporting for periods beginning January 1, 2022, we began reporting under the following three industries, which are our reportable segments: Healthcare, Education and Commercial. The Commercial segment includes all industries outside of healthcare and education, including, but not limited to, financial services and energy and utilities. In the new reporting structure, each segment includes all revenue and costs associated with engagements delivered in the respective segments' industries. The new Healthcare and Education segments include some revenue and costs historically reported in the Business Advisory segment and the Healthcare segment includes some revenue and costs historically reported in the Education segment. We also provide revenue reporting across two principal capabilities: i) Consulting and Managed Services and ii) Digital. These changes create greater transparency for investors by improving visibility into the core drivers of our business.

2. Basis of Presentation and Significant Accounting Policies

The accompanying unaudited consolidated financial statements reflect the financial position, results of operations, and cash flows as of and for the three and nine months ended September 30, 2022 and 2021. These financial statements have been prepared in accordance with the rules and regulations of the U.S. Securities and Exchange Commission ("SEC") for Quarterly Reports on Form 10-Q. Accordingly, these financial statements do not include all of the information and note disclosures required by accounting principles generally accepted in the United States of America ("GAAP") for annual financial statements. In the opinion of management, these financial statements reflect all adjustments of a normal, recurring nature necessary for the fair statement of our financial position, results of operations, and cash flows for the interim periods presented in conformity with GAAP. These financial statements should be read in conjunction with our consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2021 and our Quarterly Reports on Form 10-Q for the periods ended March 31, 2022 and June 30, 2022. Our results for any interim period are not necessarily indicative of results for a full year or any other interim period.

In order to better align with industry standards, in the first quarter of 2022, we revised the presentation of our consolidated statement of operations and other comprehensive income (loss) to present depreciation and amortization expense inclusive of amortization of intangible assets and software development costs previously presented within total direct costs and reimbursable expenses. We also aggregated immaterial line items within selling, general and administrative expenses. The change in presentation has no effect on our consolidated results, and our historical consolidated statements of operations and other comprehensive income (loss) were revised for consistent presentation.

Preparation of our consolidated financial statements requires management to make estimates and assumptions that affect the amounts reported in our consolidated financial statements and related disclosures. The business and economic uncertainty resulting from the coronavirus (COVID-19) pandemic has made such estimates and assumptions more difficult to predict. Accordingly, actual results and outcomes could differ from those estimates.

3. New Accounting Pronouncements

Not Yet Adopted

In March 2020, the Financial Accounting Standards Board ("FASB") issued Accounting Standards Update ("ASU") 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. In January 2021, the FASB clarified the scope of that guidance with the issuance of ASU 2021-01, Reference Rate Reform (Topic 848): Scope. Together, these ASUs provide optional expedients and exceptions for a limited period of time to ease the potential burden in accounting for, or recognizing the effects of,

5

---

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

reference rate reform on financial reporting under GAAP. These ASUs are optional and may be applied by entities after March 12, 2020, but no later than December 31, 2022. Our senior secured credit facility and related interest rate swaps are indexed to LIBOR, and we expect to adopt this standard when LIBOR is discontinued and a successor rate is established under these contracts. We do not expect the adoption of these ASUs to have a material impact on our consolidated financial statements.

4. Goodwill and Intangible Assets

The table below sets forth the changes in the carrying amount of goodwill by reportable segment for the nine months ended September 30, 2022.

			Healthcare						Education						Commercial(1)						Total
Balance as of December 31, 2021:
Goodwill			$	642,951					$	121,570					$	312,250					$	1,076,771
Accumulated impairment losses			(208,081)						—						(247,811)						(455,892)
Goodwill, net as of December 31, 2021			434,870						121,570						64,439						620,879
Goodwill reallocation(1)			18,057						(1,417)						(16,640)						—
Goodwill recorded in connection with business acquisitions(2)(3)			162						2,082						718						2,962
Goodwill, net as of September 30, 2022			$	453,089					$	122,235					$	48,517					$	623,841

(1)The goodwill balance as of December 31, 2021 shown within the Commercial segment related to our Business Advisory segment prior to the modification of our operating model. Effective January 1, 2022, we reallocated a portion of the goodwill within our Business Advisory segment to our Healthcare and Education segments. The remaining goodwill was allocated to our new Commercial segment.

(2)On January 18, 2022, we completed the acquisition of AIMDATA, LLC ("AIMDATA"), an advisory and implementation consulting services firm focused on strategy, technology and business transformation. The results of operations of AIMDATA are included within our consolidated financial statements as of the acquisition date and allocated among our three operating industries, which are our reportable segments, based on the engagements delivered by the business. The acquisition of AIMDATA is not significant to our consolidated financial statements.

(3)In the first quarter of 2022, we finalized the measurement of assets acquired, including goodwill, and liabilities assumed in the acquisition of Whiteboard Communications Ltd. ("Whiteboard"), a student enrollment advisory firm that helps colleges and universities with recruitment initiatives and financial aid strategies that we acquired in December 2021. The results of operations of Whiteboard are included in our consolidated financial statements and results of operations of our Education segment from the date of acquisition.

First Quarter 2022 Goodwill Reallocation

Effective January 1, 2022, we modified our operating model to expand and more deeply integrate our industry expertise with our digital, strategic and financial advisory capabilities. To align with the new operating model, effective with reporting for periods beginning January 1, 2022, we began reporting under the following three industries, which are our reportable segments: Healthcare, Education and Commercial. The Commercial segment includes all industries outside of healthcare and education, including, but not limited to, financial services and energy and utilities. In the new reporting structure, each segment includes all revenue and costs associated with engagements delivered in the respective segments' industries. The new Healthcare and Education segments include some revenue and costs historically reported in the Business Advisory segment and the Healthcare segment includes some revenue and costs historically reported in the Education segment.

6

---

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

The three reportable segments of Healthcare, Education and Commercial are also our reporting units for goodwill impairment testing purposes. As a result of the reorganization, we reallocated the goodwill balances of our historical reporting units to our new reporting units based on the relative estimated fair values of each component of the historical reporting units to be allocated to the new reporting units. Additionally, we performed a goodwill impairment test on the goodwill balances of each of our reporting units as of January 1, 2022 by comparing the fair value of the reporting unit to its carrying value, including the reallocated goodwill. Based on the results of the goodwill impairment test, we determined the fair values of the Healthcare, Education, and Commercial reporting units exceeded their carrying values by 37%, 199%, and 105%, respectively. As such, we concluded that there was no indication of goodwill impairment for all three reporting units as of January 1, 2022.

We relied on the income approach to estimate the fair value of the reporting units for both the goodwill reallocation and the goodwill impairment test. The income approach utilized a discounted cash flow analysis, which involved estimating the expected after-tax cash flows that will be generated by each business and then discounting those cash flows to present value, reflecting the relevant risks associated with each reporting unit and the time value of money. This approach requires the use of significant estimates and assumptions, including forecasted revenue growth rates, forecasted EBITDA margins, and discount rates that reflect the risk inherent in the future cash flows. In estimating future cash flows, we relied on internally generated ten-year forecasts. Our forecasts are based on historical experience, current backlog, expected market demand, and other industry information.

Intangible Assets

Intangible assets as of September 30, 2022 and December 31, 2021 consisted of the following:

									As of September 30, 2022												As of December 31, 2021
			Useful Life  (in years)						Gross Carrying Amount						Accumulated Amortization						Gross Carrying Amount						Accumulated Amortization
Customer relationships			6 to 13						$	73,942					$	55,361					$	75,908					$	53,421
Technology and software			2 to 5						13,330						7,383						13,330						5,607
Trade names			6						6,000						5,717						6,000						5,148
Non-competition agreements			2 to 5						920						278						2,020						1,347
Customer contracts			1						—						—						260						101
Total									$	94,192					$	68,739					$	97,518					$	65,624

Identifiable intangible assets with finite lives are amortized over their estimated useful lives. Customer relationships and customer contracts, as well as certain trade names and technology and software, are amortized on an accelerated basis to correspond to the cash flows expected to be derived from the assets. All other intangible assets with finite lives are amortized on a straight-line basis.

Intangible asset amortization expense was $2.8 million and $2.2 million for the three months ended September 30, 2022 and 2021, respectively; and $8.5 million and $6.9 million for the nine months ended September 30, 2022 and 2021. The table below sets forth the estimated annual amortization expense for the intangible assets recorded as of September 30, 2022.

Year Ending December 31,						Estimated Amortization Expense
2022						$	11,198
2023						$	7,904
2024						$	4,514
2025						$	3,386
2026						$	2,435

Actual future amortization expense could differ from these estimated amounts as a result of future acquisitions, dispositions, and other factors.

7

---

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

5. Revenues

For the three months ended September 30, 2022 and 2021, we recognized revenues of $285.4 million and $224.0 million, respectively. Of the $285.4 million recognized in the third quarter of 2022, we recognized revenues of $3.5 million from obligations satisfied, or partially satisfied, in prior periods, which was primarily due to the release of allowances on receivables from clients and unbilled services. Of the $224.0 million recognized in the third quarter of 2021, we recognized revenues of $4.3 million from obligations satisfied, or partially satisfied, in prior periods, of which $2.2 million was due to the release of allowances on receivables from clients and unbilled services and $2.1 million was primarily due to changes in the estimates of our variable consideration under performance-based billing arrangements.

For the nine months ended September 30, 2022 and 2021, we recognized revenues of $818.7 million and $657.3 million, respectively. Of the $818.7 million recognized in the first nine months of 2022, we recognized revenues of $4.7 million from obligations satisfied, or partially satisfied, in prior periods, of which $2.5 million was due to changes in the estimates of our variable consideration under performance-based billing arrangements and $2.2 million was primarily due to the release of allowances on receivables from clients and unbilled services. Of the $657.3 million recognized in the first nine months of 2021, we recognized revenues of $22.1 million from obligations satisfied, or partially satisfied, in prior periods, of which $14.6 million was due to changes in the estimates of our variable consideration under performance-based billing arrangements, and $7.5 million was primarily due to the release of allowances on receivables from clients and unbilled services.

As of September 30, 2022, we had $156.3 million of remaining performance obligations under engagements with original expected durations greater than one year. These remaining performance obligations exclude variable consideration which has been excluded from the total transaction price due to the constraint and performance obligations under time-and-expense engagements which are recognized in the amount invoiced. Of the $156.3 million of performance obligations, we expect to recognize approximately $23.8 million as revenue in 2022, $63.8 million in 2023, and the remaining $68.7 million thereafter. Actual revenue recognition could differ from these amounts as a result of changes in the estimated timing of work to be performed, adjustments to estimated variable consideration in performance-based arrangements, or other factors.

Contract Assets and Liabilities

The payment terms and conditions in our customer contracts vary. Differences between the timing of billings and the recognition of revenue are recognized as either unbilled services or deferred revenues in the consolidated balance sheets.

Unbilled services include revenues recognized for services performed but not yet billed to clients. Services performed that we are not yet entitled to bill because certain events, such as the completion of the measurement period or client approval in performance-based engagements, must occur are recorded as contract assets and included within unbilled services, net. The contract asset balance as of September 30, 2022 and December 31, 2021 was $28.2 million and $23.7 million, respectively. The $4.5 million increase primarily reflects timing differences between the completion of our performance obligations and the amounts billed or billable to clients in accordance with their contractual billing terms.

Client prepayments and retainers are classified as deferred revenues and recognized over future periods in accordance with the applicable engagement agreement and our revenue recognition policy. Our deferred revenues balance as of September 30, 2022 and December 31, 2021, was $20.4 million and $19.2 million, respectively. The $1.2 million increase primarily reflects timing differences between client payments in accordance with their contract terms and the completion of our performance obligations. For the three and nine months ended September 30, 2022, $1.5 million and $18.0 million of revenues recognized were included in the deferred revenues balance as of December 31, 2021.

8

---

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

6. Earnings Per Share

Basic earnings per share excludes dilution and is computed by dividing net income by the weighted average number of common shares outstanding for the period, excluding unvested restricted common stock. Diluted earnings per share reflects the potential reduction in earnings per share that could occur if securities or other contracts to issue common stock were exercised or converted into common stock under the treasury stock method. Such securities or other contracts include unvested restricted stock awards, unvested restricted stock units, and outstanding common stock options, to the extent dilutive. In periods for which we report a net loss, diluted weighted average common shares outstanding excludes all potential common stock equivalents as their impact on diluted net loss per share would be anti-dilutive.

Earnings per share under the basic and diluted computations are as follows: 

			Three Months Ended September 30,												Nine Months Ended September 30,
			2022						2021						2022						2021
Net income			$	17,741					$	13,727					$	58,468					$	31,929
Weighted average common shares outstanding – basic			20,109						21,242						20,511						21,574
Weighted average common stock equivalents			506						289						388						330
Weighted average common shares outstanding – diluted			20,615						21,531						20,899						21,904
Net income per basic share			$	0.88					$	0.65					$	2.85					$	1.48
Net income per diluted share			$	0.86					$	0.64					$	2.80					$	1.46

The number of anti-dilutive securities excluded from the computation of the weighted average common stock equivalents presented above for the three and nine months ended September 30, 2022 and 2021 were less than 0.1 million shares, and related to unvested restricted stock and outstanding common stock options.

In November 2020, our board of directors authorized a share repurchase program permitting us to repurchase up to $50 million of our common stock through December 31, 2021. Through the third quarter of 2022, our board of directors authorized extensions of the share repurchase program through December 31, 2023 and increased the authorized amount to $200 million. In the fourth quarter of 2022, our board of directors increased the authorized amount under the share repurchase program from $200 million to $300 million. The amount and timing of repurchases under the share repurchase program were and will continue to be determined by management and depend on a variety of factors, including the trading price of our common stock, capacity under our credit facility, general market and business conditions, and applicable legal requirements. All shares repurchased and retired are reflected as a reduction to our basic weighted average shares outstanding based on the trade date of the share repurchase.

In the three and nine months ended September 30, 2022, we repurchased and retired 685,641 and 1,706,587 shares for $45.6 million and $97.9 million, respectively, including 38,568 shares for $2.6 million which were settled in the fourth quarter of 2022. Additionally, in the first quarter of 2022, we settled the repurchase of 3,820 shares for $0.2 million that were accrued as of December 31, 2021. In the three and nine months ended September 30, 2021, we repurchased and retired 518,045 and 1,169,126 shares for $25.0 million and $60.2 million, respectively. As of September 30, 2022, $32.3 million remained available for share repurchases under our share repurchase program.

9

---

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

7. Financing Arrangements

A summary of the carrying amounts of our debt follows:

			September 30, 2022						December 31, 2021
Senior secured credit facility			$	341,000					$	230,000
Promissory note due 2024			—						2,780
Total long-term debt			341,000						232,780
Current maturities of long-term debt			—						(559)
Long-term debt, net of current portion			$	341,000					$	232,221

Senior Secured Credit Facility

The Company has a $600 million senior secured revolving credit facility, subject to the terms of a Second Amended and Restated Credit Agreement dated as of March 31, 2015, as amended to date (as amended and modified the "Amended Credit Agreement"), that becomes due and payable in full upon maturity on September 27, 2024. The Amended Credit Agreement provides the option to increase the revolving credit facility or establish term loan facilities in an aggregate amount of up to $150 million, subject to customary conditions and the approval of any lender whose commitment would be increased, resulting in a maximum available principal amount under the Amended Credit Agreement of $750 million. The initial borrowings under the Amended Credit Agreement were used to refinance borrowings outstanding under a prior credit agreement, and future borrowings under the Amended Credit Agreement may be used for working capital, capital expenditures, acquisitions of businesses, share repurchases, and general corporate purposes.

Fees and interest on borrowings vary based on our Consolidated Leverage Ratio (as defined in the Amended Credit Agreement). At our option, borrowings under the Amended Credit Agreement will bear interest at one, two, three or six-month LIBOR or an alternate base rate, in each case plus the applicable margin. The applicable margin will fluctuate between 1.125% per annum and 1.875% per annum, in the case of LIBOR borrowings, or between 0.125% per annum and 0.875% per annum, in the case of base rate loans, based upon our Consolidated Leverage Ratio at such time.

Amounts borrowed under the Amended Credit Agreement may be prepaid at any time without premium or penalty. We are required to prepay the amounts outstanding under the Amended Credit Agreement in certain circumstances, including upon an Event of Default (as defined in the Amended Credit Agreement). In addition, we have the right to permanently reduce or terminate the unused portion of the commitments provided under the Amended Credit Agreement at any time.

The loans and obligations under the Amended Credit Agreement are secured pursuant to a Second Amended and Restated Security Agreement and a Second Amended and Restated Pledge Agreement (the “Pledge Agreement”) with Bank of America, N.A. as collateral agent, pursuant to which the Company and the subsidiary guarantors grant Bank of America, N.A., for the ratable benefit of the lenders under the Amended Credit Agreement, a first-priority lien, subject to permitted liens, on substantially all of the personal property assets of the Company and the subsidiary guarantors, and a pledge of 100% of the stock or other equity interests in all domestic subsidiaries and 65% of the stock or other equity interests in each “material first-tier foreign subsidiary” (as defined in the Pledge Agreement).

The Amended Credit Agreement contains usual and customary representations and warranties; affirmative and negative covenants, which include limitations on liens, investments, additional indebtedness, and restricted payments; and two quarterly financial covenants as follows: (i) a maximum Consolidated Leverage Ratio (defined as the ratio of debt to consolidated EBITDA) of 3.75 to 1.00; however the maximum permitted Consolidated Leverage Ratio will increase to 4.00 to 1.00 upon the occurrence of certain transactions, and (ii) a minimum Consolidated Interest Coverage Ratio (defined as the ratio of consolidated EBITDA to interest) of 3.50 to 1.00. Consolidated EBITDA for purposes of the financial covenants is calculated on a continuing operations basis and includes adjustments to add back non-cash goodwill impairment charges, share-based compensation costs, certain non-cash restructuring charges, pro forma historical EBITDA for businesses acquired, and other specified items in accordance with the Amended Credit Agreement. For purposes of the Consolidated Leverage Ratio, total debt is on a gross basis and is not netted against our cash balances. At September 30, 2022, we were in compliance with these financial covenants with a Consolidated Leverage Ratio of 2.06 to 1.00 and a Consolidated Interest Coverage Ratio of 18.36 to 1.00.

Borrowings outstanding under the Amended Credit Agreement at September 30, 2022 totaled $341.0 million. These borrowings carried a weighted average interest rate of 3.6%, including the effect of the interest rate swaps described in Note 9 “Derivative Instruments and Hedging Activity.” Borrowings outstanding under the Amended Credit Agreement at December 31, 2021 were $230.0 million and carried a weighted average interest rate of 2.7%, including the effect of the interest rate swaps. The borrowing capacity under the revolving credit facility is reduced by any outstanding borrowings under the revolving credit facility and outstanding letters of credit. At September 30, 2022,

10

---

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

we had outstanding letters of credit totaling $0.7 million, which are used as security deposits for our office facilities. As of September 30, 2022, the unused borrowing capacity under the revolving credit facility was $258.3 million.

Promissory Note due 2024

On June 30, 2017, in conjunction with our purchase of an aircraft related to the acquisition of Innosight, we assumed from the sellers of the aircraft a promissory note with an outstanding principal balance of $5.1 million. In the first quarter of 2022, we completed the sale of the aircraft to a third-party and used a portion of the sale proceeds to pay the remaining principal and unpaid interest on the promissory note. Prior to the repayment of the promissory note, the principal balance of the promissory note was subject to scheduled monthly principal payments until the maturity date of March 1, 2024. Under the terms of the promissory note, we paid interest on the outstanding principal amount at a rate of one month LIBOR plus 1.97% per annum. At December 31, 2021, the outstanding principal amount of the promissory note was $2.8 million, and the aircraft had a carrying amount of $3.7 million. As a result of the sale, we recognized a gain of $1.0 million in the first quarter of 2022 and we no longer own any aircraft.

8. Restructuring Charges

Restructuring charges for the three and nine months ended September 30, 2022 were $1.3 million and $5.0 million. The $1.3 million of restructuring charges recognized in the third quarter of 2022 included $0.7 million of rent and related expenses, net of sublease income, for previously vacated office spaces, $0.5 million for the early termination of a contract, and $0.1 million of employee-related expenses. The $5.0 million of restructuring charges incurred in the first nine months of 2022 included $1.7 million of employee-related expenses, $1.7 million of rent and related expenses, net of sublease income, for previously vacated office spaces, $0.6 million for third-party transaction expenses related to the modification of our operating model, $0.5 million for the early termination of a contract, $0.3 million of accelerated amortization of capitalized software implementation costs for a cloud-computing arrangement that is no longer in use, and $0.1 million related to the divestiture of our Life Sciences business in the fourth quarter of 2021.

Restructuring charges for the three and nine months ended September 30, 2021 were $1.7 million and $3.2 million, respectively. The $1.7 million of restructuring charges recognized in the third quarter of 2021 consisted of $0.7 million of third-party transaction expenses related to the evaluation of the divestiture of our Life Sciences business, $0.5 million of rent and related expenses, net of sublease income, for previously vacated office spaces, and $0.5 million of employee-related expenses. Of the $3.2 million restructuring charge incurred in the first nine months of 2021, $1.8 million related to rent and related expenses, net of sublease income, and accelerated depreciation on furniture and fixtures for vacated office spaces; $0.9 million for third-party transaction expenses related to the evaluation of the divestiture of our Life Sciences business; and $0.5 million of employee-related expenses recognized in the third quarter of 2021.

The table below sets forth the changes in the carrying amount of our restructuring charge liability by restructuring type for the nine months ended September 30, 2022.

			Employee Costs						Office Space Reduction						Other						Total
Balance as of December 31, 2021			$	573					$	—					$	567					$	1,140
Additions			1,711						—						1,085						2,796
Payments			(1,432)						—						(1,025)						(2,457)
Adjustments			—						87						40						127
Balance as of September 30, 2022			$	852					$	87					$	667					$	1,606

All of the $0.9 million restructuring charge liability related to employee costs at September 30, 2022 is expected to be paid in the next 12 months and is included as a component of accrued payroll and related benefits in our consolidated balance sheet. The $0.1 million restructuring charge liability related to office space reductions at September 30, 2022 is included as a component of accrued expenses and other current liabilities. All of the $0.7 million other restructuring charge liability at September 30, 2022 is expected to be paid over the next 12 months and is included as a component of accrued expenses and other current liabilities in our consolidated balance sheet.

9. Derivative Instruments and Hedging Activity

In the normal course of business, we use forward interest rate swaps to manage the interest rate risk associated with our variable-rate borrowings under our senior secured credit facility and we use non-deliverable foreign exchange forward contracts to manage the foreign currency exchange rate risk related to our operations in India. We do not use derivative instruments for trading or other speculative purposes.

11

---

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

We have designated all of our derivative instruments as cash flow hedges. Therefore, changes in the fair value of the interest rate swaps and foreign exchange forward contracts are recorded to other comprehensive income (“OCI”) to the extent effective and reclassified to earnings upon settlement.

Interest Rate Swaps

We are party to forward interest rate swap agreements with an aggregate notional amount of $200.0 million as of September 30, 2022 and December 31, 2021. Under the terms of the interest rate swap agreements, we receive from the counterparty interest on the notional amount based on one month LIBOR and we pay to the counterparty a stated, fixed rate. The forward interest rate swap agreements have staggered maturities through August 31, 2027.

As of September 30, 2022, it was anticipated that $4.1 million of the gains, net of tax, related to interest rate swaps and currently recorded in accumulated other comprehensive income will be reclassified into interest expense, net of interest income in our consolidated statement of operations within the next 12 months.

Foreign Exchange Forward Contracts

As of September 30, 2022, we are party to non-deliverable foreign exchange forward contracts with an aggregate notional amount of INR 405.1 million, or $5.0 million based on the exchange rate in effect as of September 30, 2022. These foreign exchange forward contracts will mature monthly through July 2023 to hedge a portion of our forecasted monthly Indian Rupee-denominated expenses against foreign currency fluctuation with the United States dollar.

As of September 30, 2022, it was anticipated that $0.1 million of the losses, net of tax, related to foreign exchange forward contracts and currently recorded in accumulated other comprehensive income will be reclassified into direct costs in our consolidated statement of operations within the next 12 months.

The table below sets forth additional information relating to our derivative instruments as of September 30, 2022 and December 31, 2021.

									Fair Value
Derivative Instrument			Balance Sheet Location						September 30, 2022						December 31, 2021
Interest rate swaps			Prepaid expenses and other current assets						$	5,335					$	—
Interest rate swaps			Other non-current assets						6,536						1,210
Total Assets									$	11,871					$	1,210
Interest rate swaps			Accrued expenses and other current liabilities						$	—					$	1,604
Interest rate swaps			Deferred compensation and other liabilities						—						149
Foreign exchange forward contracts			Accrued expenses and other current liabilities						99						—
Total Liabilities									$	99					$	1,753

All of our derivative instruments are transacted under the International Swaps and Derivatives Association (ISDA) master agreements. These agreements permit the net settlement of amounts owed in the event of default and certain other termination events. Although netting is permitted, it is our policy to record all derivative assets and liabilities on a gross basis in our consolidated balance sheet. Refer to Note 11 “Other Comprehensive Income (Loss)” for additional information on our derivative instruments.

12

---

Table of Contents

HURON CONSULTING GROUP INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Tabular amounts in thousands, except per share amounts)

(Unaudited)

10. Fair Value of Financial Instruments

Certain of our assets and liabilities are measured at fair value. Fair value is defined as the price that would be received to sell an asset or the price that would be paid to transfer a liability in an orderly transaction between market participants at the measurement date. GAAP establishes a fair value hierarchy for inputs used in measuring fair value and requires companies to maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy consists of three levels based on the objectivity of the inputs as follows:

Level 1 Inputs						Quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.
Level 2 Inputs						Quoted prices in active markets for similar assets or liabilities; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; or inputs that are derived principally from or corroborated by observable market data by correlation or other means.
Level 3 Inputs						Unobservable inputs for the asset or liability, and include situations in which there is little, if any, market activity for the asset or liability.

The table below sets forth our fair value hierarchy for our financial assets and liabilities measured at fair value on a recurring basis as of September 30, 2022 and December 31, 2021.<

Level 1

Level 2

Level 3

Total

September 30, 2022

Assets: